during pregnancy where infection can result in chorioamnionitis, preterm premature rupture of 48 membranes (PPROM), preterm labor, stillbirth, and neonatal sepsis. Mechanisms by which GBS 49 infection results in adverse pregnancy outcomes are still incompletely understood. This study 50 evaluated interactions between GBS and placental macrophages. The data demonstrate that in 51 response to infection, placental macrophages release extracellular traps capable of killing GBS. 52 4 pregnancy, preterm birth, intrauterine growth restriction, and preeclampsia (16) . Multiple mechanisms 79 exist to support maternal-fetal tolerance including production of anti-inflammatory cytokines that alter 80 the number and function of immune cells at the maternal-fetal interface (17) (18) (19) . Unfortunately, 81 infection is a common complication of pregnancy. Bacterial infection of the fetal membranes, known 82 as chorioamnionitis, occurs most often by ascending infection from the vagina (8, 20, 21) . During 83 infection, bacterial products are recognized by pathogen recognition receptors, which then stimulate 84 production of proinflammatory cytokines (20, 22, 23) . These inflammatory mediators initiate a 85 cascade of events that result in neutrophil infiltration into the fetal membranes, production and 86 release of matrix metalloproteases (MMPs), and cervical contractions which eventually result in 87 membrane rupture and preterm birth (24) . 88
Macrophages represent 20-30% of the leukocytes within gestational tissues (25). In particular, 89 fetally-derived macrophages, called Hofbauer cells or placental macrophages (PMs), play key roles in 90 placental invasion, angiogenesis, tissue remodeling, and development (26, 27) . The inflammatory 91 state of these cells is carefully regulated throughout pregnancy. As the pregnancy progresses the M2 92 or anti-inflammatory and tissue remodeling phenotype predominates to supports fetal development 93 (28-31). PMs contribute to immune tolerance by secretion of anti-inflammatory cytokines, which 94 suppress production of proinflammatory cytokines (32-35). Disruption of appropriate macrophage 95 polarization is associated with abnormal pregnancies including spontaneous abortions, preterm labor, 96
and preeclampsia (28). We sought to understand how bacterial infection alters PM functions, and how 97 these responses may contribute to pathologic pregnancies. These studies demonstrate that both PMs 98 and a model macrophage cell line, the PMA-differentiated THP-1 macrophage-like cells, release 99 macrophage extracellular traps (METs) in response to bacterial infection in a process that is 00 dependent upon the generation of reactive oxygen species (ROS). METs, reminiscent of neutrophil 01 extracellular traps (NETs), have recently been recognized as structures released by macrophages 02 under a number of conditions including infection (36). PM METs contain histones, myeloperoxidase, 03 and neutrophils elastase as well as several MMPs, and MET structures are found within human fetal 04 membranes infected with GBS ex vivo. 05 06
Results: 07
Placental macrophages release METs in response to GBS: 08
To understand PM responses to GBS at the host-pathogen interface, isolated PMs were infected ex 09 vivo with GBS and cellular interactions examined using field-gun high-resolution scanning electron 10 microscopy (SEM). At one hour following infection, fine, reticular structures were noted extending 11 from macrophages, and these structures were less abundant in uninfected samples ( Figure 1A , lower 12 panels). These structures resembled NETs. Recent reports suggest that macrophages also release 13 fibers composed of DNA and histones, known as METs (36, 37) . To determine if these structures 14
were METs, macrophages were evaluated by scanning laser confocal microscopy after staining with 15 the DNA binding dye SYTOX Green, which demonstrated extracellular structures extending from PMs 16 that were not seen when PMs were treated with DNase I (Figure 1A , top panels). Cells were then 17 evaluated to assess the degree to which these structures contained proteins previously associated 18 with NETs and METs, including histones, myeloperoxidase, and neutrophil elastase (36, 37). Each of 19 these proteins co-localized to extracellular DNA structures extending from the PMs ( Figure 1B) . The 20 staining for MET-associated proteins was specific as no fluorescent signal was seen when either a 21 secondary conjugated antibody alone or an isotype control secondary conjugated antibody was used 22 to evaluate these structures (Sup. Figure 1 ). Together, these data suggest that these structures are 23
METs released by PMs. The extent of MET release was then quantified, and PMs co-cultured with 24 GBS released significantly more METs than uninfected cells and DNase I treatment degraded these 25 extracellular structures ( Figure 1C ). Additionally, MET release by PMs occurred in a dose dependent 26 fashion (Sup. Fig 2A) , and MET release was not GBS strain or bacterial species specific as PMs 27 infected with GBS strain GB037, a capsular type V strain, Escherichia coli, or heat killed bacteria 28 resulted in similar MET release (Sup. Figure 3) . 29 6 One major immunologic function of extracellular traps is the ability to immobilize and kill 30 microorganisms through the locally high concentration of cellular proteins including histones that have 31 antimicrobial effects (37, 38) . In order to investigate the bactericidal activity of PM METs, PMs were 32 co-cultured with GBS cells alone or in the presence of DNase I. After 1 hour of infection, significantly 33 more bacterial colony forming units (CFU) were recovered from co-cultures treated with DNase I, 34
suggesting that PM METs have bactericidal activity and eliminating METs with DNase treatment 35 impaired bacterial killing ( Figure 1D ). To verify that DNase treatment itself did not result in significant 36 PM cell death, thus decreasing bactericidal ability, PMs were incubated with DNase I for one hour 37 prior to washing and stimulating PMs with heat-killed GBS for 24 hours. PM TNF-α release was used 38 as a marker of macrophage viability and function; there was no difference in TNF-α from supernatants 39 of cells treated with DNase compared to untreated cells (Sup. Figure 2B ). Additionally, live-dead 40 bacterial staining of PMs infected with GBS demonstrated dead GBS cells adjacent to MET fibers 41 (Sup. Figure 2C ). Together, these data provide evidence that PMs release METs in response to 42 bacteria and that these structures are capable of killing GBS cells. Figure 4A ). However, GBS infected PMs did not exhibit a 49 significant difference in IL-1β release or TUNEL positive cells compared to uninfected cells treated 50 with vehicle controls at 1 hour (Sup. Figure 4B -D). 51
52

PMA-differentiated THP-1 macrophage-like cells release METs after direct bacterial contact: 53
Experiments were conducted to determine if MET responses against GBS were specific to PMs or 54 might represent a broader macrophage response. The immortalized monocyte-like cell line, THP-1 55 cells, was evaluated after differentiation into macrophage-like cells with phorbol 12-myristate 13-56 acetate (PMA) for 24 hours. THP-1 macrophage-like cells infected with GBS released significantly 57 more METs than uninfected cells, and DNase I treatment degraded the MET structures (Sup. Figure  58 5). The THP-1 MET response required contact with bacterial cells, as treatment of the macrophage-59 like cells with sterile filtered bacterial culture supernatant did not stimulate MET release compared to 60 uninfected cells. 61 62
Actin polymerization is required for GBS-induced MET release: 63
Actin polymerization has been shown to be important for MET release (36). A similar role of 64 cytoskeletal changes on GBS-induced MET release in THP-1 macrophage-like cells was examined. 65
Treatment prior to infection with the actin polymerization inhibitor, cytochalasin D, but not nocodazole, 66
which inhibits microtubule polymerization, inhibited MET release compared to GBS infected, 67 untreated cells (Sup. Figure 5 ). As noted below (and shown in Figure 2B ), cytochalasin D also 68 inhibited MET release by human PMs infected with GBS. 69 70
Placental macrophage MET responses require ROS production: 71
Neutrophil release of NETs occurs in a ROS-dependent manner (40). It was hypothesized that MET 72 release from PMs may require production of ROS. Treatment of PMs prior to infection with the 73 NADPH oxidase inhibitor diphenyleneiodonium (DPI) inhibited release of METs, whereas treatment of 74 uninfected macrophages with PMA resulted in similar levels of MET release to GBS infected cells 75 (Figure 2A, B) . As with the THP-1 macrophage-like cells, treatment of PMs with cytochalasin D prior 76 to infection inhibited MET release. To further define that ROS production was associated with MET 77 release a fluorescent ROS dye was used to evaluate PMs for intracellular ROS production. Treatment 78 with DPI inhibited ROS production, and GBS infection as well as PMA treatment of uninfected PMs 79 resulted in significantly more ROS production than uninfected cells ( Figure 2C , D). Interestingly, 80 pretreatment with cytochalasin D decreased levels of intracellular ROS production similar to that of 81 DPI, suggesting that pretreatment with the actin cytoskeletal inhibitor may actually be preventing MET 82 release by impeding ROS production. Additionally, ROS production in these experiments mirrored the 83 degree of MET release under similar conditions ( Figure 2B ), suggesting that ROS production is 84 necessary for MET release from these macrophages. METs were present within gestational tissues in response to infection, fetal membrane tissues from 07 9 healthy, term, non-laboring caesarian sections were obtained, excised, and organized into transwell 08 structures, creating two chambers separated by the fetal membranes. GBS cells were added to the 09 choriodecidual surface and infection was allowed to progress for 48 hours prior to fixing tissues for 10 immunohistochemistry and immunofluorescence analysis. CD163-positive cells were found localized 11 to an area of GBS microcolonies within the membranes that demonstrated histone staining extending 12 beyond the nucleus and into the extracellular space, suggesting the release of a MET-like structure 13 ( Figure 4A ). Immunofluorescence staining demonstrated CD163-positive cells associated with 14 extracellular material that stained positive for histones and MMP-9 ( Figure 4B ). Additional staining of 15 fetal membrane tissues using neutrophil elastase as was previously described for identification of 16
NETs in tissues (45), identified cells within the choriodecidua with long extensions that stained 17 strongly for neutrophil elastase that co-localized to histone H3 and DNA staining (Sup. Figure 6 ). 18
Cells releasing MET-like structures could be compared to cells with intact nuclei and neutrophil 19
elastase staining limited to granule structures suggesting that cells releasing MET-like structures had 20 undergone cellular changes consistent with etosis. 21 22
Discussion: 23
In the initial description of NETs in 2004, several potential immune functions were described including 24 the trapping and killing of microorganisms and degradation of bacterial products (37). Release of 25 cellular DNA and proteins within extracellular traps has also been associated with autoimmune 26 pathology in systemic lupus erythematosus and anti-neutrophil cytoplasmic autoantibodies (ANCA)-27 associated vasculitis, as well as and in diseases of aseptic inflammation (46-50). Other leukocytes 28 including mast cells, eosinophils, basophils and macrophages have now been shown to release 29 extracellular trap structures (36, 51-54). 30
In this manuscript, PMs are added to a growing list of monocytes and tissue differentiated 31 macrophages capable of releasing METs, which includes human alveolar macrophages, glomerular 32 macrophages, peripheral blood monocytes, and macrophages from other mammalian and non-33 mammalian species (36). These data demonstrate that human PMs and PMA-differentiated THP-1 34 macrophage-like cells release METs in response to bacterial infection and after treatment with the 35 protein kinase C agonist, PMA. The present data correlate with previous reports that neutrophils and 36 murine macrophages release traps in response to GBS infection and that METs are capable of killing 37 GBS cells (55, 56) . 38
These data also demonstrate that PM METs contain many proteins previously identified in 39
NETs, including histones, neutrophil elastase, and myeloperoxidase (37). These results mirror other 40
MET investigations demonstrating that diverse macrophages produce and release proteins including 41 neutrophil elastase within MET structures. For example, human glomerular macrophages releasing 42
METs containing myeloperoxidase has been demonstrated in cases of ANCA-associated 43 glomerulonephritis and human alveolar macrophages have been shown to release METs containing 44 histones and MMP-9 (57, 58). Human blood monocytes release METs containing H3 histones, 45 myeloperoxidase, lactoferrin, and neutrophil elastase in response to Candida albicans cells, and 46
similar MET contents have been demonstrated in THP-1 macrophage-like cells infected with 47
Mycobacterium massiliense (59, 60). 48
Similar to neutrophil etosis, these data suggest that ROS generation is necessary for PM MET 49 release as this response was inhibited by treatment with the NADPH oxidase inhibitor, DPI. These 50 results mirror reports that inhibition of ROS production via chemical inhibitors resulted in diminished 51
MET release in bovine, caprine, murine, and human macrophages (61-65). In neutrophils, ROS act to 52 break down intracellular membranes and activates neutrophil elastase, which translocates to the 53 nucleus where it degrades histones and promotes chromatin decondensation (39). Myeloperoxidase 54 is thought to contribute chromatin decondensation by a enzymatic-independent mechanism (39). It is 55 unclear at this time if neutrophil elastase and myeloperoxidase perform similar roles in macrophages. 56
Our data indicate an increase in LDH release during infection, which is consistent with reports 57 that MET release results in cell death (66). Etosis has been noted to be distinct from other cellular 58 death pathways including pryoptosis and apoptosis. At one hour of infection when MET responses 59 were identified, there was no significant difference in TUNEL staining or IL-1β release suggesting that 60 PM METs occur by a distinct pathway. This is notable as previous reports have shown that the GBS 61 toxin β-hemolysin is capable of inducing pryoptosis of macrophages, though in this study infection 62 was allowed to progress for 4 hours, longer than that required for the PM MET response (67). 63
Previous studies have also demonstrated that GBS is capable to inducing macrophage apoptosis, but 64 again this occurred over longer periods of infection than the one hour that was capable of inducing 65 MET responses (68). MET release. Another possibility is that the pretreatment with cytochalasin D may interrupt trafficking 78 of the NADPH oxidase complex, thus impairing ROS production. NADPH oxidase is a complex of six 79 components, and the cytosolic proteins p40 phox and p47 phox are known to interact with F-actin; 80 treatment with cytochalasins have been shown to interrupt NADPH complex formation and lead to 81 impaired ROS formation (72, 73). Timing of the cytochalasin treatment is important, as treatment of 82 cells after pre-stimulation with molecules such as LPS, which stimulates NADPH oxidase assembly, 83 may actually increase generation of ROS in these cells (74). In our study, macrophages were 84 pretreated with cytochalasin D and were not stimulated prior to infection. It remains unclear if the 85 conflicting literature with regards to the impact of cytoskeletal inhibition on extracellular traps may be 86 explained by the timing of cytoskeletal inhibition and subsequent effects on ROS production. 87
PMs were found to produce and release several MMPs within MET structures. During 88 chorioamnionitis, inflammatory mediators lead to the production and release of several 89 metalloproteinases including MMP-1, MMP-7, MMP-8, and MMP-9 (75, 76). MMP-9 is considered to 90 be the major MMP responsible for collagenase activity within the membranes, but many other MMPs 91 are thought to contribute to the processes of membrane weakening (75, 77). This study reinforces 92 and expands previous reports that identified placental leukocytes as being able to secrete MMPs 93
including MMP-1, -7, and -9 (78). Several MMPs have been implicated in preterm birth and pathologic 94 pregnancies. MMP-1 and MMP-9 were found to be elevated in placental tissues of women with 95 preterm births compared to women delivering at full term (79). MMP-1 and neutrophil elastase have 96 been shown to stimulate uterine contractions (80) . Interestingly, proteomic comparisons of amniotic 97 fluid from women with premature preterm rupture of membranes demonstrated increases in histones 98 (H3, H4, H2B), myeloperoxidase, neutrophil elastase, and MMP-9 in women with histologic 99 chorioamnionitis and proven intrauterine infection, which likely represents the influx of inflammatory 00 cells into these tissues and potentially release of extracellular traps (81). MMP-12, or macrophage 01 metalloelastase, is a key mediator of the breakdown of elastase and has been shown to be important 02 for spiral artery remodeling during parturition, but to date there are no studies demonstrating changes 03 in MMP-12 release during cases of pathologic pregnancies (82). MMP-12 is better studied in 04 conditions of lung pathology including emphysema, and alveolar macrophages are known to release 05 MMP-12 in METs during infection, suggesting that protease release from leukocytes may contribute 06 to this disease process (65). Analogous to a controlled burn, we speculate that tethering MMPs to 07 MET structures allows the host to control the release of these potent enzymes, thereby limiting their 08 capacity to broadly weaken membrane structure in response to infection. 09
MET release appears to occur within fetal membrane tissue as demonstrated by our 10 immunohistochemistry and immunofluorescence data. This report adds to the growing relevance of 11 13 these structures within cases of disease pathology. NETs have previously been identified in placenta 12 tissues from women with pregnancies complicated by systemic lupus erythematosus and 13 preeclampsia (83, 84) . NETs were also found in fetal membrane samples of women with 14 spontaneous preterm labor due to acute chorioamnionitis (85). Interestingly, in this report, antibody 15 staining with histone H3 and neutrophil elastase was used to denote NET structures, but given our 16 data, this staining pattern would not have differentiated METs from NETs. Additionally, our group and 17 others have demonstrated that in animal models of vaginal colonization and perinatal infection with 18 GBS, neutrophils traffic to GBS-infected gestational tissues and release NETs containing 19 antimicrobial peptides including lactoferrin as a means to control bacterial growth and invasion (86-20 88) . 21
In conclusion, we demonstrate that placental macrophages as well as PMA-differentiated THP-22
1 cells respond to bacterial infection by releasing METs. These MET structures contain proteins 23 similar to NETs, including histones, myeloperoxidase, and neutrophil elastase. MET release from 24 these macrophages can be stimulated in the absence of bacterial cells with PMA and is inhibited by 25 pathways that impair ROS production. Placental macrophage METs contain several MMPs that have 26 been implicated in pathologic pregnancies including premature rupture of membranes. MET 27 structures were identified in human fetal membrane tissue infected ex vivo. Together these results 28 suggest that placental macrophages, which are thought to help maintain maternal fetal tolerance and 29 aid in extracellular matrix remodeling, are capable of responding to GBS infection in a way that may 30 trap and kill GBS cells but may also release important mediators of fetal membrane extracellular 31 matrix digestion that could potentially contribute to infection related pathologies including preterm 32 rupture of membrane and preterm birth. 33 34
Materials and Methods: 35
Placental macrophage isolation and culture: Human placental macrophages (PM) and fetal 36 membrane tissues were isolated from placental tissues from women who delivered healthy infants at 37 full term by cesarean section (without labor). De-identified tissue samples were provided by the 38 Cooperative Human Tissue Network, which is funded by the National Cancer Institute. All tissues 39
were collected in accordance with Vanderbilt University Institutional Review Board (approval 131607). 40
Macrophage isolation occurred as previously described (89); briefly, placental villous tissue was 41 minced followed by digestion with DNase, collagenase, and hyaluronidase (all from Sigma-Aldrich, St. 42
Louis MO). Cells were filtered, centrifuged, and CD14+ cells were isolated using the magnetic MACS 43 hour, supernatants were collected and cells were fixed with 2.0% paraformaldehyde and 2.5% 79 glutaraldehyde in 0.05 M sodium cacodylate buffer (Electron Microscopy Sciences, Hatfield PA) for at 80 least 12 hours prior to processing for microscopy. 81 82 Field-emission gun scanning electron microscopy: Following treatment and infection as above, 83 macrophages were incubated in 2.0% paraformaldehyde and 2.5% glutaraldehyde in 0.05 M sodium 84 cacodylate buffer for at least 12 hours prior to sequential dehydration with increasing concentrations 85 of ethanol. Samples were dried at the critical point, using a CO 2 drier (Tousimis, Rockville MD), 86
mounted onto an aluminum stub, and sputter coated with 80/20 gold-palladium. A thin strip of 87 colloidal silver was painted at the sample edge to dissipate sample charging. Samples were imaged 88 with an FEI Quanta 250 field-emission gun scanning electron microscope. Quantification of 89 macrophages producing extracellular traps was determined by evaluating scanning electron 90 micrograph images at 750X magnification and counting total macrophages and those macrophages 91 releasing extracellular traps. Extracellular traps were defined as previously described with typical 92 appearing fibers extending from the cell body into the extracellular space (36). at an MOI of 20:1 as described above. As indicated some PMs were incubated with100 U/mL DNase 12 I during infection to degrade extracellular trap structures as has been described previously (37). At 13 the end of 1 hour, DNase I was added to previously untreated wells for 10 minutes to release trapped 14 bacterial cells. Supernatants were collected and PMs were permeabilized with 0.05% Tween-20 in 15 sterile ice-cold water to release intracellular bacteria. Samples were vortexed vigorously, serially 16 diluted, and plated on blood agar plates to enumerate bacterial cells. Untreated PMs were compared 17 to DNase I treated cells and data are expressed as the percent colony forming units (CFU) recovered 18 compared to untreated cells. To further evaluate bacterial killing, PMs were seeded onto coverslips 19 and infected as above. Following infection, cells were stained using the Live/Dead BacLight Bacterial 20
Viability Kit (Invitrogen) prior to confocal laser scanning microscopy. preserve CellRox Reagent signal. Coverslips were then mounted onto glass slides and visualized 50 with a visualized with a Zeiss LSM 710 confocal microscope as above. Images obtained were 51 analyzed using Fiji Version 1.0 (94). In order to quantify ROS production, a cellular ROS production 52 index was calculated using the following equation: ((total image intensity -(mean background 53 fluorescence x image area)))/total macrophages counted) x (number of macrophages with ROS 54 production/total macrophages counted). Images capturing only ROS staining (without other 55 stains/channels) were measured to determine the total corrected fluorescence for the total image 56 area. Mean background fluorescence was determined by at least 3 different measurements in areas 57 of the image lacking cellular contents (95) . Data are presented as the mean +/-SE ROS cellular 58 production index of 10 images per sample. were incubated at 37°C in ambient air containing 5% CO 2 for 48 hours at which time membrane 82 tissues were fixed in 10% neutral buffered formalin prior to paraffin embedding. 83
Human fetal membrane immunohistochemistry staining: Tissues were cut to 5 μm sections and 84 multiple sections were placed on each slide for analysis. For immunohistochemistry, slides were 85 deparaffinized and heat induced antigen retrieval was performed on the Bond Max automated IHC 86 stainer (Leica Biosystems, Buffalo Grove IL) using their Epitope Retrieval 2 solution for 5-20 minutes. 87
Slides were incubated with a rabbit polyclonal anti-GBS antibody (abcam, ab78846), rabbit polyclonal 88 anti-histone H3 antibody (abcam, ab8580), or a mouse monoclonal anti-CD163 antibody (MRQ-26, 89
Cell Marque, Rocklin CA) for 1 hour. The Bond Polymer Refine detection system (Leica Biosystems) 90 20 was used for visualization. Slides were the dehydrated, cleared and coverslipped before light 91 microscopy analysis was performed. 92
Human fetal membrane immunofluorescence staining: For immunofluorescence evaluation of 93
METs within fetal membrane tissue, tissues were fixed and sectioned as above. Sections were briefly 94 incubated with xylene to deparrafinize. Tissues were blocked for greater than 1 hour with 10% bovine 95 serum albumins (Sigma-Aldrich) before staining with 1/100 dilutions of mouse monoclonal anti-H3 96 antibodies conjugated with Alexa Fluor® 647 (ab205729, abcam), rabbit monoclonal anti-CD163 97 antibodies conjugated with Alexa Fluor® 488 (ab218293, abcam), and mouse monoclonal anti-MMP-98 9 antibodies conjugated with Alexa Fluor® 405 (NBP-259699AF405, Novus biological, Littleton CO) 99 overnight at room temperature. Additional tissues staining were conducted as previously described 00 (45). Tissues were deparrafinized and then incubated in R universal Epitope Recovery Buffer 01 (Electron Microscopy Sciences, Hatfield PA) at 50°C for 90 minutes. Samples were then rinsed in 02 deionized water three times followed by washing with TRIS-buffered saline (TBS, pH 7.4). Samples 03 were permeablized for 5 minutes with 0.5% Triton X100 in TBS at room temperature followed by 3 04 washes with TBS. Samples were then blocked with TBS with 10% BSA for 30 minutes prior to 05 incubation with 1:50 dilutions of rabbit poly-colonal anti-neutrophil elastase antibodies (481001, 06
MilliporeSigma, Burlington MA) and mouse monoclonal anti-H3 antibodies conjugated with Alexa 07
Fluor® 647 in blocking buffer at room temperature overnight. The following day, samples were 08 washed in TBS followed by repeat blocking with blocking buffer for 30 minutes at room temperature 09 before incubation with 1/00 dilution of Alexa Fluor® 488 conjugated donkey anti-rabbit IgG 10 (Invitrogen) for 4 hours at room temperature. Samples were then washed and incubated with 5 μM 11
Hoechst 33342 for 30 minutes to stain nuclei. After final washes, slides were dried and coverslipped. and evaluated for MMP-8 (3B) and MMP-9 (3C) concentrations by ELISA. GBS infection results in a 86 significant increase in MMP-8 (Student's t test, t = 3.599, df = 7, p = 0.0087) and MMP-9 (Student's t 87 test, t = 3.160, df = 10, p = 0.0102) release compared to uninfected cells. 3D: PMs release active 88
MMPs in response to GBS. Supernatant from PM-GBS co-culture was evaluated for MMP activity 89 using a MMP Activity Assay to assess global MMP activity within co-culture supernatants. 90 Supernatant from GBS infected cells had 53% more MMP activity compared to uninfected PMs 91 (Student's t test, t = 2.439, df = 11, p = 0.0329). THP-1 cells were incubated with 100 nM PMA for 24 hours prior to infection to induce differentiation 56 to macrophage-like cells. Cells were infected with GBS at an MOI of 20:1 for 1 hour. As indicated, 57 cells were pre-incubated with DNase I, cytochalasin D, nocodazole, or exposed to 10% volume of 58 sterile filtered bacterial supernatant from GBS cultures grown overnight to steady state. After 59 infection, cells were fixed and evaluated by confocal microscopy after staining with SYTOX Green 60 
